P. Schoenfeld Asset Management (PSAM)’s Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share AUS.WS Stock Holding History
Bought
Maintained
Sold
P. Schoenfeld Asset Management (PSAM)'s AUS.WS Position: Q4 2022 in Review
P. Schoenfeld Asset Management (PSAM) sold out of Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (AUS.WS) in Q4 2022, closing a stake of 93,972 shares — an estimated $9K sold.
P. Schoenfeld Asset Management (PSAM) first reported a position in AUS.WS in Q2 2021 and held it in 6 quarters. The position peaked at $1.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold AUS.WS as of Q4 2022.
- P. Schoenfeld Asset Management (PSAM) reported no remaining Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- P. Schoenfeld Asset Management (PSAM) sold 93,972 Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q4 2022, an estimated $9K.
- P. Schoenfeld Asset Management (PSAM) first reported a position in Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
- P. Schoenfeld Asset Management (PSAM)'s Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $1.4M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q4 2022.
Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q4 2022, filed 14 Feb 2023.